New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Phosphoproteomic profiling reveals the complex interplay of immune cells in tumors

Researchers from the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical Proteomic Tumor Analysis Consortium of the National Institutes of Health,

February 14, 2024

Leading Sales & Marketing Intelligence Solutions for Pharma Industry

Leading account and intent-based sales and marketing providers and technology solutions for the pharmaceutical industry: Introduction In the vast global landscape of the pharmaceutical industry,

November 16, 2024

Vascular risk factors influence cognitive health differently in men and women with Alzheimer’s disease

Researchers utilize imaging findings to elucidate how Alzheimer’s dementia can present considerable variations depending on the sex of the individual.

September 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.